Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India (SOLID)

AstraZeneca

Status: Completed

Conditions: Type 2 Diabetes Mellitus; Dyslipidemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01292018

NIS-CIN-DUM-2010/1

Details and patient eligibility

About

The purpose of study to assess the control of dyslipidemia in the Indian diabetic population treated with any hypolipidemic agent.

Enrollment: 5,400 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult who is a known Type 2 diabetic as per the ADA 2010 criteria OR controlled diabetic (taking any antidiabetic medication)
• Patients in the study will have been on lipid lowering drugs at a stable dose for the last three months before the designated study visit.

Exclusion criteria

• Type 1 diabetic patients
• Patients with a history of hepatic or renal diseases
• Hypertension due to organic diseases